Muvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 KRAKEN trial show.Concentrations of Lp(a) cholesterol are genetically determined and...
Read moreMuvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 KRAKEN trial show.Concentrations of Lp(a) cholesterol are genetically determined and...
Read moreCHICAGO -- Secondhand permanent pacemaker use in poorer countries, following thorough cleaning and repackaging, has not resulted in patient harm so far, according to the My Heart Your Heart trialists....
Read moreCHICAGO -- The novel myeloperoxidase (MPO) inhibitor mitiperstat failed to improve quality of life or functional capacity in heart failure with mid-range to preserved ejection fraction (HFmrEF, HFpEF), the phase...
Read moreSeveral hundred primary care physicians at Mass General Brigham (MGB) notified the National Labor Relations Board on Friday that they support unionization, a move they called historic and increasingly common...
Read moreOne of the leading public health associations came out Monday against President-elect Trump's nomination of vaccine skeptic Robert F. Kennedy Jr. for HHS secretary. Kennedy's selection, which would have to...
Read moreMembers of the Healthcare Infection Control Practices Advisory Committee (HICPAC) voted Friday to defend what some have called weak standards of infection control for healthcare settings, agreeing nearly unanimously that...
Read moreMore than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated. Among 25,531 participants in the National Health and Nutrition Examination Survey (NHANES)...
Read morePositive 3-year results from the phase III PHOTON study were presented at the recent American Academy of Ophthalmology (AAO) meeting, demonstrating that patients with diabetic macular edema (DME) achieved sustained...
Read moreLAS VEGAS — In the clinical experience of Julie C. Harper, MD, patients with ocular rosacea don’t always present with telltale signs like red or bloodshot eyes.“Sometimes they just have...
Read moreWASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those with lingering low-level symptoms, a single-center study found -- casting doubt on current guidelines...
Read moreA single dose of the CRISPR-based gene-editing therapy NTLA-2002 significantly reduced angioedema attacks compared with placebo in patients with hereditary angioedema, according to results from a phase II randomized study...
Read moreCHICAGO -- Gene therapy for Danon disease, a rare inherited cause of hypertrophic cardiomyopathy, appeared to improve or stabilize the structure and function of the heart over a period of...
Read moreSAN DIEGO — The prevalence of and number of deaths from alcohol-associated liver disease (ALD) and alcohol use disorder (AUD) are growing among people age 70 and older in the...
Read moreIt can be hard to keep weight offTero Vesalainen/Getty Images People with obesity who lose weight often put it back on, which may partly be driven by lasting changes to...
Read moreWASHINGTON -- Patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA) may not have to worry so much about increased cardiovascular risk -- if they're taking statins, research presented...
Read moreLazarus is an adjunct professor of psychiatry. "The Last Leaf" by O. Henry, published in 1907 in his collection The Trimmed Lamp and Other Stories of the Four Million, follows...
Read moreCHICAGO -- Electronic nudges increased uptake of flu vaccines among patients with a history of acute myocardial infarction (MI), results from three Danish randomized trials showed. Among over 2 million...
Read moreAdding fecal microbiota therapy to standard care for steroid-ineligible severe alcoholic-associated hepatitis appeared safe and effective in a small randomized trial from India. Survival at 90 days reached 73% with...
Read moreWhile high-dose chemotherapy and autologous hematopoietic cell transplantation (HCT) can deepen remissions and improve outcomes for multiple myeloma, these treatments come with significant risks, particularly for patients with comorbidities or...
Read moreMinimal residual disease (MRD) has emerged as a significant marker in the treatment of multiple myeloma (MM), allowing clinicians to make more informed decisions about therapy. MRD testing helps gauge...
Read more© 2022 NewsHealth.
© 2022 NewsHealth.